Calling cannabis a gateway drug is ‘a scare tactic’

Organisation: Position: Deadline Date: Location:

The theory that cannabis is a gateway drug is nothing more than a scare tactic; if anything it may have protective properties, a Cape Times report quotes British psychiatrist and neuro-psychopharmacologist David Nutt as saying.

It was the sixth day of the trial looking into the legalisation of marijuana in the Pretoria High Court. Nutt told the court that the theory of the substance being a gateway to harder drugs had been used repeatedly and unjustifiably. He said: “The theory of it being a gateway simply states that if someone uses the drug, then they would easily move on to harder drugs. But there is no evidence to that effect. If anything, it is the social factor and prohibition of cannabis that becomes the gateway.”

Nutt said he believed having the drug regarded as illegal moved it to the black market and anyone looking for it would consequently become exposed to drug dealers peddling harder drugs. This was because they wanted those coming to them to become hooked and as such would offer users samples with the cannabis.

According to the report, the professor cited the Dutch model, which saw prosecution of cannabis users suspended and made the drug available in cafés, thus eliminating the chances of their youth coming into contact with drug dealers.

Dr Raquel Peyraube, a specialist in problematic use of drugs from Uruguay, said she was pleased that South Africa was taking the first steps in making a positive change to legislation governing cannabis.

Cape Times report

Receive Medical Brief's free weekly e-newsletter



Related Posts

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.